Meetings

Engage with a panel of APPs who work in various aspects of HCT and cellular therapy, including education, research, industry and leadership roles. Learn about unique APP roles as you consider expanding and enriching your professional journey.

We are excited to announce an upcoming virtual roundtable on Wednesday, April 23, at 2 p.m. CDT that will delve into insights and key takeaways from ASH Annual Meeting and 2025 Tandem Meetings. This will be a great opportunity to explore and discuss latest advancements impacting BMT and cellular therapy and connect with your peers on these recent developments in our field. 

During the webinar, Drs. White and Nezalova-Henriksen will present two articles related to: (a) Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic HSCT for older patients with AML or MDS and (b) Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients.

The Joint ASTCT + EBMT Basic and Translational Scientific Meeting is a 2.5-day conference focused on cutting-edge basic and translational biology in the field. The meeting focuses on fundamental themes and novel technologies with an emphasis on unpublished and innovative science.

The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 9 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.

FOCIS 2025 will be the 25th Annual Meeting of the Federation of Clinical Immunology Societies. The Scientific Program Committee will develop the FOCIS 2025 Scientific Program for the target audience to fulfill unmet educational needs in the translational immunology scientific and medical community.